fbpx

Research Reports

On a Dip

Shares of Catamaran (CTRX) are on a dip, and provide excellent upside of more than 50% to the stock’s Fair Value.

Read More »

Tension is Building

Shares of Catamaran (CTRX) are now basing after a strong run-up last year. Now tension is building and CTRX could be ready to make a move in 2014.

Read More »

Go Cigna!

Catamaran (CTRX) just signed a new deal with Cigna, and I will replace Francesca’s (FRAN) with CTRX in the Aggressive Growth Portfolio.

Read More »

All About Cigna

What’s on the mind of investors in regards to Catamaran (CTRX)? It’s all about the Cigna business, which was a third of 2012 sales.

Read More »

You Deserve a Rest

Take a break Catamaran (CTRX), you deserve a break after the 75% rise your stock’s had this year. Looking at estimates, it seems like another rise is on the horizon.

Read More »

Look to the Future

We need to look to the future with Catamaran (CTRX). CTRX is overvalued now, but profit growth is set to jump 65% next year.

Read More »

Waiting for the Merger

Catalyst Health Systems (CHSI) is going through a merger with (more like be acquired by) SXC Health Solutions (SXCI). I’m holding CHSI and waiting.

Read More »

Top of the Range

Catalyst Health Solutions (CHSI) has jumped this year, but the stock is close to its 2012 fair value. Upside is still solid for long-term investors.

Read More »

Time to Rest

Catalyst Health Solutions (CHSI) is the same place it was a quarter ago — sitting around fair value. It just ended a run and needs some time before moving higher.

Read More »

Where’s the Beef?

Catalyst Health Solutions (CHSI) just pulled off a coup, buying Walgreens’ pharmacy benefit business. Customers will rise from 7 million to 18 million — but profits estimates didn’t jump. Where’s the beef? All I see here is bun.

Read More »

Business Has Never Been Better

Catalyst Health Solutions’ (CHSI) business has never been better. The company just said revenues could climb 30% in 2011. With a P/E of 20 and expected profit growth of around 30%, this stable stock has ample upside.

Read More »

Earnings

Not a member? Sign up here for $25 a month.